Cargando…

The Individual Effects of Cyclin-Dependent Kinase Inhibitors on Head and Neck Cancer Cells—A Systematic Analysis

SIMPLE SUMMARY: This study examined the therapeutic potential of a combined therapy approach, based on clinical approved drugs (5-FU, Cisplatin, cetuximab) and cyclin-dependent kinase inhibitors (CDKi, dinaciclib, palbociclib, THZ1). We identified individual effects on head and neck squamous cell ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schoenwaelder, Nina, Salewski, Inken, Engel, Nadja, Krause, Mareike, Schneider, Björn, Müller, Michael, Riess, Christin, Lemcke, Heiko, Skorska, Anna, Grosse-Thie, Christina, Junghanss, Christian, Maletzki, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157193/ https://www.ncbi.nlm.nih.gov/pubmed/34063457 http://dx.doi.org/10.3390/cancers13102396

Ejemplares similares

Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
por: Riess, Christin, et al.
Publicado: (2020)

Preclinical Head and Neck Squamous Cell Carcinoma Models for Combined Targeted Therapy Approaches
por: Schoenwaelder, Nina, et al.
Publicado: (2022)

Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors
por: Salewski, Inken, et al.
Publicado: (2021)

Long-term survivor of metastatic squamous-cell head and neck carcinoma with occult primary after cetuximab-based chemotherapy: A case report
por: Große-Thie, Christina, et al.
Publicado: (2021)

Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies—Current Understanding, (Pre-)Clinical Application and Promising Approaches
por: Richter, Anna, et al.
Publicado: (2021)

Establishment and characterization of patient-derived head and neck cancer models from surgical specimens and endoscopic biopsies
por: Strüder, Daniel, et al.
Publicado: (2021)

CDK4/6 blockade provides an alternative approach for treatment of mismatch-repair deficient tumors
por: Salewski, Inken, et al.
Publicado: (2022)

Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib
por: Riess, Christin, et al.
Publicado: (2020)

In vivo vaccination with cell line-derived whole tumor lysates: neoantigen quality, not quantity matters
por: Salewski, Inken, et al.
Publicado: (2020)

Cyclin-dependent kinase inhibitors exert distinct effects on patient-derived 2D and 3D glioblastoma cell culture models
por: Riess, Christin, et al.
Publicado: (2021)

HGG-07. CYCLIN-DEPENDENT KINASES AS TARGET STRUCTURES FOR CANCER THERAPY – A COMPARATIVE IN VITRO ANALYSIS ON PATIENT-DERIVED GLIOBLASTOMA CELL CULTURE MODELS
por: Riess, Christin, et al.
Publicado: (2020)

Combined vaccine-immune-checkpoint inhibition constitutes a promising strategy for treatment of dMMR tumors
por: Salewski, Inken, et al.
Publicado: (2021)

Short-term immune-checkpoint inhibition partially rescues perturbed bone marrow hematopoiesis in mismatch-repair deficient tumors
por: Krone, Paula, et al.
Publicado: (2023)

Feasibility and Effects of a Supervised Exercise Program Suitable for Independent Training at Home on Physical Function and Quality of Life in Head and Neck Cancer Patients: A Pilot Study
por: Felser, Sabine, et al.
Publicado: (2020)

The addition of arginine deiminase potentiates Mithramycin A-induced cell death in patient-derived glioblastoma cells via ATF4 and cytochrome C
por: Linke, Charlotte, et al.
Publicado: (2023)

Aberrant expression of cyclin A in head and neck cancer
por: Lotayef, M, et al.
Publicado: (2000)

Quantitative Evaluation of the Sarcomere Network of Human hiPSC-Derived Cardiomyocytes Using Single-Molecule Localization Microscopy
por: Lemcke, Heiko, et al.
Publicado: (2020)

Quantitative Analysis of Cyclin Dl Messenger RNA Expression in Head and Neck Squamous Cell Carcinomas
por: Monden, Nobuya, et al.
Publicado: (1997)

Chemo-immunotherapy improves long-term survival in a preclinical model of MMR-D-related cancer
por: Maletzki, Claudia, et al.
Publicado: (2019)

Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma
por: Muller, D, et al.
Publicado: (2006)

The Effects of Hypoxic Preconditioned Murine Mesenchymal Stem Cells on Post-Infarct Arrhythmias in the Mouse Model
por: Ahmad, Beschan, et al.
Publicado: (2022)

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
por: Hecht, Markus, et al.
Publicado: (2020)

GMP-conformant on-site manufacturing of a CD133(+) stem cell product for cardiovascular regeneration
por: Skorska, Anna, et al.
Publicado: (2017)

HGG-13. Combined CDK inhibition and arginine-deprivation as targeted therapy for arginine-auxotrophic glioblastoma multiforme cells
por: Riess, Christin, et al.
Publicado: (2022)

Ultradeep targeted sequencing reveals low allele frequencies of somatic JAK2 and MPL variants in patients with abdominal vein thromboses: results of an ongoing prospective prevalence study in Mecklenburg-West Pomerania
por: Grunwald, Luise, et al.
Publicado: (2020)

Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells
por: Lemcke, Heiko, et al.
Publicado: (2017)

Amplification of Cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC)
por: Sticht, C, et al.
Publicado: (2005)

Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
por: Riess, Christin, et al.
Publicado: (2022)

PEGylation increases antitumoral activity of arginine deiminase of Streptococcus pyogenes
por: Schwarz, Rico, et al.
Publicado: (2021)

Cardiomyocyte Transplantation after Myocardial Infarction Alters the Immune Response in the Heart
por: Vasudevan, Praveen, et al.
Publicado: (2020)

Impact of the Intra- and Inter-observer Variability in the Delineation of Parotid Glands on the Dose Calculation During Head and Neck Helical Tomotherapy
por: Piotrowski, T., et al.
Publicado: (2015)

Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas and Paired Normal Mucosae Reveals Cyclin D1 Deregulation and Compensatory Effect of Cyclin D2
por: Novotný, Jiří, et al.
Publicado: (2020)

Role of E-cadherin and cyclin D1 as predictive markers of aggression and clonal expansion in head and neck squamous cell carcinoma
por: Shergill, Khushdeep, et al.
Publicado: (2018)

Preclinical Evaluation of the Association of the Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, and Cetuximab in Squamous Cell Carcinoma of the Head and Neck
por: van Caloen, Gabrielle, et al.
Publicado: (2021)

Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck
por: Trieu, Vanessa, et al.
Publicado: (2018)

CCR2 macrophage response determines the functional outcome following cardiomyocyte transplantation
por: Vasudevan, Praveen, et al.
Publicado: (2023)

Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction
por: Maletzki, Claudia, et al.
Publicado: (2023)

Monitoring the maturation of the sarcomere network: a super-resolution microscopy-based approach
por: Skorska, Anna, et al.
Publicado: (2022)

Unraveling the Heterogeneous Mutational Signature of Spontaneously Developing Tumors in MLH1(−/−) Mice
por: Gladbach, Yvonne Saara, et al.
Publicado: (2019)

Postsurgical pyoderma gangrenosum and flap necrosis in a head and neck cancer patient following neck dissection
por: Arebro, Julia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fstq6loni0ihb8ff9omrtam7nu